Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

7.36
Delayed Data
As of 3:59pm ET
 -0.10 / -1.34%
Today’s Change
2.80
Today|||52-Week Range
8.31
+45.74%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues2.5M4.2M5.8M6.8M
 
 
 
 
 
Cost of Goods Sold612.0K3.5M1.5M1.8M
 
 
 
 
 
Depreciation And Amortization145.0K148.0K165.0K261.0K
 
 
 
 
 
 
Operating ExpensesGross Income1.8M532.0K4.1M4.8M
 
 
 
 
 
General Expenses28.7M31.4M29.6M28.2M
 
 
 
 
 
Research And Development8.0M11.2M8.0M7.6M
 
 
 
 
 
Total Operating Expenses29.5M35.0M31.2M30.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.0M-30.8M-25.5M-23.4M
 
 
 
 
 
Extraordinary Charge0.000.000.00-2.0M
 
 
Interest Expense On Debt------15.7M
 
 
Other Expenses114.0K100.0K-12.3M6.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.9M-30.7M-37.8M-40.9M
 
 
 
 
 
Income Taxes-23.0K-22.0K-23.0K-20.0K
 
 
 
 
 
Net Income-26.9M-30.7M-37.8M-41.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS104.6M105.2M105.2M105.6M
 
 
 
 
 
Shares To Calculate EPS Diluted104.6M105.2M105.2M105.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.26-$0.29-$0.36-$0.39
 
 
 
 
 
EPS Diluted-$0.26-$0.29-$0.36-$0.39